Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance
Abbott Laboratories shares hit a three-month high and recorded their best day in 24 years following strong Q2 2026 results.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Abbott Laboratories has reported second-quarter 2026 results featuring stronger-than-expected profits. Consequently, the company is raising its full-year earnings per share (EPS) guidance.
Coverage from the Wall Street Journal and qz.com emphasizes that sales rose due to diagnostics growth. Barron's notes that the stock is currently leading the S&P 500, while Investor's Business Daily reports a 14% increase in share price.
Future focus remains on the company's ability to meet its boosted 2026 profit outlook following these quarterly gains.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 2h ago.
Quick answers
Why did Abbott's sales increase?
According to the Wall Street Journal, sales rose due to growth in diagnostics.
How has the stock performed following the report?
The stock rose 14%, hitting a three-month high and its best day in 24 years.
What change did Abbott make to its financial projections?
The company is raising its full-year earnings per share (EPS) guidance.
Coverage (9)
- Abbott's Q2 2026 earnings call: What drove results and what should investors watch next? Abbott · 5h ago
- Abbott Laboratories shares jump as earnings beat estimates and company raises 2026 outlook Yahoo Finance · 5h ago
- Abbott rises as guidance hike tops expectations (ABT:NYSE) Seeking Alpha · 5h ago
- Abbott raises 2026 profit forecast on strength in diagnostics, medical devices Reuters · 5h ago
- Abbott, Up 14%, Strikes Three-Month High After Boosting 2026 Profit Outlook Investor's Business Daily · 5h ago
- Abbott posted stronger-than-expected profit and is raising its full-year earnings outlook qz.com · 5h ago
- Abbott Laboratories Sales Rise on Diagnostics Growth WSJ · 5h ago
- Abbott Stock Is Leading the S&P 500 After Earnings for Its Best Day in 24 Years Barron's · 5h ago
- Abbott Reports Second-Quarter 2026 Results and Raises Full-Year EPS Guidance Abbott MediaRoom · 5h ago
Topics
Related trends
Why the Mag 7 Stocks Can Save the Stock Market Rally
A massive capital rotation is shifting focus toward the 'Magnificent 7' as a potential lifeline for the broader stock market rally.
S&P 500 futures edge lower as semiconductors fall: Live updates
S&P 500 and Nasdaq futures are declining as semiconductor stocks plunge and AI-related trading momentum slows.
Johnson & Johnson CFO Says Guidance Hike Is Just the Start
Johnson & Johnson has exceeded quarterly earnings estimates and raised its financial guidance, driven by a strong performance in its medicines unit.
Alzheimer's blood test may predict who's likely to develop symptoms in 5 to 10 years
A new blood-based test may predict the onset of Alzheimer's symptoms in healthy adults five to ten years before they appear.
U.S. stocks march higher after cooler wholesale inflation data (COMP:IND:)
U.S. stocks are trending higher following a significant drop in wholesale inflation driven by lower energy costs.
Stock futures rise on chip stocks bounce, encouraging inflation signs: Live updates
Stock futures are trending higher as strong demand for AI chipmaking equipment and M&A reports drive a tech-led rally.